Veeva Systems (NYSE:VEEV) Updates FY 2027 Earnings Guidance

Veeva Systems (NYSE:VEEV) updated its FY 2027 earnings guidance on Wednesday. The company provided earnings per share guidance of 9.050-9.050 for the period, compared to the consensus earnings per share estimate of 8.370. The company issued revenue guidance of $3.6 billion-$3.6 billion, compared to the consensus revenue estimate of $3.6 billion. Veeva Systems also updated its Q2 2027 guidance to 2.210-2.220 EPS.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on VEEV. Oppenheimer reaffirmed an “outperform” rating and set a $225.00 price target on shares of Veeva Systems in a report on Thursday. Citigroup lifted their price target on Veeva Systems from $176.00 to $190.00 and gave the stock a “neutral” rating in a report on Thursday. Mizuho decreased their price target on Veeva Systems from $295.00 to $270.00 and set an “outperform” rating for the company in a report on Thursday. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $275.00 price target on shares of Veeva Systems in a report on Thursday. Finally, Morgan Stanley boosted their target price on Veeva Systems from $205.00 to $215.00 and gave the company an “equal weight” rating in a report on Thursday, March 5th. Eighteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $250.96.

Veeva Systems Stock Down 0.1%

Shares of VEEV stock opened at $178.56 on Friday. The stock has a market capitalization of $29.16 billion, a PE ratio of 31.83, a price-to-earnings-growth ratio of 0.79 and a beta of 0.95. Veeva Systems has a 52-week low of $148.05 and a 52-week high of $310.50. The stock’s 50-day moving average price is $166.27 and its 200 day moving average price is $195.90.

Veeva Systems (NYSE:VEEV) last issued its quarterly earnings results on Wednesday, June 3rd. The technology company reported $2.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.10. The firm had revenue of $882.95 million for the quarter, compared to analysts’ expectations of $857.73 million. Veeva Systems had a return on equity of 13.89% and a net margin of 28.37%.The firm’s revenue for the quarter was up 16.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.97 EPS. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. Analysts expect that Veeva Systems will post 6.45 earnings per share for the current fiscal year.

Insider Transactions at Veeva Systems

In related news, Director Priscilla Hung sold 750 shares of the business’s stock in a transaction dated Thursday, April 30th. The stock was sold at an average price of $155.64, for a total value of $116,730.00. Following the transaction, the director owned 3,253 shares in the company, valued at $506,296.92. The trade was a 18.74% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is owned by company insiders.

Key Headlines Impacting Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva beat first-quarter estimates, with EPS of $2.24 and revenue of $882.9 million, while Q2 revenue guidance also came in above expectations, supporting the case for continued growth. Article Title
• Positive Sentiment: Management raised fiscal 2027 outlook and highlighted AI initiatives, including Falcon AI agents and new platform expansion, which could improve investor sentiment around product innovation and future monetization. Article Title
• Positive Sentiment: Several brokers remain constructive, with firms like Oppenheimer, RBC, Needham, BTIG, and Baird reiterating bullish ratings and high price targets, suggesting some analysts see meaningful upside despite the recent pullback.
• Neutral Sentiment: Other analysts turned more cautious, including Goldman Sachs, UBS, BMO, and Citigroup, which lowered price targets, adding to the mixed read-through from the earnings report.
• Negative Sentiment: Some commentary pointed to concerns about the legacy CRM business and customer migration dynamics, which may be tempering enthusiasm around the AI story and weighing on the shares.

Hedge Funds Weigh In On Veeva Systems

Several institutional investors have recently added to or reduced their stakes in the stock. J.Safra Asset Management Corp increased its position in Veeva Systems by 2,940.0% during the 4th quarter. J.Safra Asset Management Corp now owns 152 shares of the technology company’s stock worth $34,000 after purchasing an additional 147 shares during the period. Raiffeisen Bank International AG grew its holdings in shares of Veeva Systems by 59.8% in the 4th quarter. Raiffeisen Bank International AG now owns 155 shares of the technology company’s stock worth $35,000 after acquiring an additional 58 shares during the period. Measured Wealth Private Client Group LLC acquired a new stake in shares of Veeva Systems in the 3rd quarter worth approximately $45,000. Rakuten Securities Inc. grew its holdings in shares of Veeva Systems by 56.7% in the 2nd quarter. Rakuten Securities Inc. now owns 163 shares of the technology company’s stock worth $47,000 after acquiring an additional 59 shares during the period. Finally, Palisade Asset Management LLC acquired a new stake in shares of Veeva Systems in the 3rd quarter worth approximately $66,000. Institutional investors and hedge funds own 88.20% of the company’s stock.

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.